Icon plc Stock
Price
Target price
€75.88
€75.88
-2.940%
-2.3
-2.940%
€193.73
17:49 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
We can see a decrease in the price for Icon plc. Compared to yesterday it has lost -€2.300 (-2.940%).
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 193 € there is potential for a 154.35% increase which would mean more than doubling the current price of 75.88 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -2.940% | -39.746% | -50.425% | -55.967% | -49.545% | -63.806% | - |
| Alkermes plc | 0.000% | -1.418% | 2.206% | -17.751% | 17.797% | 7.481% | 66.467% |
| United Therapeutics | 1.460% | -0.076% | -0.973% | 12.472% | -7.138% | 68.636% | 185.468% |
| Iovance Biotherapeutics Inc. | -1.100% | -0.389% | 7.264% | -59.014% | -8.179% | -66.718% | -94.426% |
Comments
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
News
3 Healthcare Pathbreakers With Long-Term Tailwinds
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals
